homehealthcare News

Bharat Biotech's Covaxin cleared based on non human primate study: Expert panel

healthcare | Jan 5, 2021 5:14 PM IST

Bharat Biotech's Covaxin cleared based on non-human primate study: Expert panel

Mini

The minutes of the vaccine expert group meeting is out and it shows that the approval to Bharat Biotech's Covaxin was based on non-human primate challenge study.

The minutes of the vaccine expert group meeting is out and it shows that the approval of Bharat Biotech's Covaxin was based on non-human primate challenge study.

Recommended Articles

View All

The minutes of the Subject Expert Committee (SEC) revealed now that the approval under clinical trial mode that has been given based on non-human primate challenge study, which was submitted after multiple times when the Bharat Biotech application was rejected and sent back by the SEC.
On December, 13th SEC has told Bharat Biotech that they need to submit updated immunogenicity, safety, and efficacy dated for further consideration.
CNBC-TV18’s Archana Shukla gets more details.
To know more, watch this video.
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!

Top Budget Opinions

    Most Read

    Market Movers

    View All
    Top GainersTop Losers
    CurrencyCommodities
    CompanyPriceChng%Chng